Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $8.31 +0.61%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 5
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 5
Join SI Premium – FREE
Jefferies analyst Maury Raycroft lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $33.00 (from $36.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer
- Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK345 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
